Predicting outcome based on swenerton score in patients with metastatic breast cancer undergoing high-dose chemotherapy and autologous hematopoietic stem cell transplantation: implications for patient selection-Reference-Cited by-同舟云学术

Predicting outcome based on swenerton score in patients with metastatic breast cancer undergoing high-dose chemotherapy and autologous hematopoietic stem cell transplantation: implications for patient selection

Published:2003-05 Issue:5 Volume:9 Page:330-340
ISSN:1083-8791
Container-title:Biology of Blood and Marrow Transplantation
language:en
Short-container-title:Biology of Blood and Marrow Transplantation

Author:

Montemurro Filippo,Rondón Gabriela,Munsell Mark,Smith Terry L,Donato Michele L,Gajewski James L,Rahman Zia U,Buzdar Aman U,Champlin Richard E,Ueno Naoto T

Publisher

Elsevier BV

Subject

Transplantation,Hematology

Reference26 articles.

1. High-dose thiotepa alone and in combination regimens with bone marrow support;Antman;Semin Oncol,1990

2. A phase II study of high-dose cyclophosphamide, thiotepa, and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard-dose therapy;Antman;J Clin Oncol,1992

3. Prognostic factors for prolonged progression-free survival with high-dose chemotherapy with autologous stem-cell support for advanced breast cancer;Ayash;J Clin Oncol,1995

4. High-dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancer;Peters;J Clin Oncol,1988

5. Factors predicting long-term survival for metastatic breast cancer patients treated with high-dose chemotherapy and bone marrow support;Dunphy;Cancer,1994

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prognostic Value of EMT-Circulating Tumor Cells in Metastatic Breast Cancer Patients Undergoing High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation;Journal of Cancer;2012

2. Interleukin-2 and granulocyte–macrophage–colony-stimulating factor immunomodulation with high-dose chemotherapy and autologous hematopoietic stem cell transplantation for patients with metastatic breast cancer;International Journal of Hematology;2009-12

3. Stem Cell Transplantation for Metastatic and High-Risk Nonmetastatic Breast Cancer: A Novel Treatment Approach;Breast Cancer 2nd edition;2008

4. Circulating Tumor Cells in Metastatic Breast Cancer: Biologic Staging Beyond Tumor Burden;Clinical Breast Cancer;2007-02

5. Complete Response after High-Dose Chemotherapy and Autologous Hemopoietic Stem Cell Transplatation in Metastatic Breast Cancer Results in Survival Benefit;The Breast Journal;2006-11